SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001104659-22-014375
Filing Date
2022-02-08
Accepted
2022-02-08 18:00:30
Documents
1
Period of Report
2022-02-04

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT tm225864-2_4seq1.html 4  
1 OWNERSHIP DOCUMENT tm225864-2_4seq1.xml 4 6301
  Complete submission text file 0001104659-22-014375.txt   7666
Mailing Address 1 BRIDGE PLAZA, SUITE 275 FORT LEE NJ 07024
Business Address 1 BRIDGE PLAZA, SUITE 275 FORT LEE NJ 07024 360-837-7232
Nuvectis Pharma, Inc. (Issuer) CIK: 0001875558 (see all company filings)

IRS No.: 862405608 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences

Mailing Address C/O NUVECTIS PHARMA, INC. 1 BRIDGE PLAZA, SUITE 275 FORT LEE NJ 07024
Business Address
Shemesh Shay (Reporting) CIK: 0001896056 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-41264 | Film No.: 22603119